Pattern Bioscience: Funding, Investors & Team (Sep 2026)
Pattern Bioscience, established in 2016, is a private company focused on solving the issue of antibiotic resistance through innovative in vitro diagnostics. The company is creating an advanced clinical microbiology platform using patented phenotypic single-cell technology to quickly identify pathogens and their antibiotic reactions without the typical lengthy culture process. Pattern's Digital CultureTM technology utilizes functional endpoints to cover all resistance mechanisms, leading to more accurate and thorough diagnoses compared to rapid genotypic tests. This platform aims to provide faster and more reliable diagnoses than the current standard of care.
Pattern Bioscience has raised $96.4M across 3 funding rounds on record, the most recent an undisclosed round of $44.2M announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pattern Bioscience Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Pattern Bioscience Funding Rounds
Pattern Bioscience raised $23.5M in an undisclosed round announced in Jan 2023.
3 months later, a Series C of $28.7M was announced in Apr 2023.
2.3 years later, an undisclosed round of $44.2M was announced in Aug 2025.
Pattern Bioscience Founders and Leadership Team
Contact details for the Pattern Bioscience team: 1 of 1 has an email address on file.
Start 14-day free trial →Pattern Bioscience Funding Compared to Other Biotechnology Startups
Pattern Bioscience's latest round of $44.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pattern Bioscience in Biotechnology and Austin
Companies Similar to Pattern Bioscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Pattern Bioscience Funding FAQs
What does Pattern Bioscience do?
Pattern Bioscience, established in 2016, is a private company focused on solving the issue of antibiotic resistance through innovative in vitro diagnostics. The company is creating an advanced clinical microbiology platform using patented phenotypic single-cell technology to quickly identify pathogens and their antibiotic reactions without the typical lengthy culture process. Pattern's Digital CultureTM technology utilizes functional endpoints to cover all resistance mechanisms, leading to more accurate and thorough diagnoses compared to rapid genotypic tests. This platform aims to provide faster and more reliable diagnoses than the current standard of care.
How much funding has Pattern Bioscience raised?
Pattern Bioscience has raised $96.4M across 3 rounds on record. The most recent is an undisclosed round of $44.2M announced in Aug 2025.
When did Pattern Bioscience last raise funding?
Pattern Bioscience's most recent funding round on record is an undisclosed round of $44.2M, announced in Aug 2025.
Who is the CEO of Pattern Bioscience?
Nicolas Arab is listed as CEO at Pattern Bioscience.
Where is Pattern Bioscience headquartered?
Pattern Bioscience is based in Austin, Texas, United States.
How many employees does Pattern Bioscience have?
Pattern Bioscience is in the 51-100 employee band.
How does Pattern Bioscience's funding compare to other Biotechnology startups?
Pattern Bioscience's latest round of $44.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Pattern Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pattern Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.